Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/09/21
Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate UpdateGlobeNewsWire • 02/08/21
Why Corcept Therapeutics (CORT) Might Surprise This Earnings SeasonZacks Investment Research • 02/05/21
Corcept Therapeutics to Announce Preliminary Selected Financial Results, Provide Corporate Update and Host Conference CallGlobeNewsWire • 02/01/21
U.S. Patent Trial and Appeals Board Affirms Validity of All Claims of Corcept's U.S. Patent No.10,195,214GlobeNewsWire • 11/18/20
Corcept Therapeutics' (LAUR) CEO Eilif Serck-Hanssen on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/08/20
Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/07/20
Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2020 Results - Quick Version Earnings Call TranscriptSeeking Alpha • 11/04/20
Corcept Therapeutics (CORT) Lags Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/03/20
Corcept Therapeutics Initiates Second Phase 2 Trial of Miricorilant to Treat Weight Gain Caused by Antipsychotic MedicationGlobeNewsWire • 09/10/20
Is the Options Market Predicting a Spike in Corcept Therapeutics (CORT) Stock?Zacks Investment Research • 09/03/20